OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The NCI-MATCH trial: lessons for precision oncology
Peter J. O’Dwyer, Robert J. Gray, Keith T. Flaherty, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1349-1357
Closed Access | Times Cited: 80
Peter J. O’Dwyer, Robert J. Gray, Keith T. Flaherty, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1349-1357
Closed Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 48
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 48
Novel clinical trial designs emerging from the molecular reclassification of cancer
Mina Nikanjam, Shumei Kato, Teresa Allen, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 2
Mina Nikanjam, Shumei Kato, Teresa Allen, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 2
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors
Yoshiaki Nakamura, Hiroshi Ozaki, Makoto Ueno, et al.
Nature Medicine (2024)
Open Access | Times Cited: 12
Yoshiaki Nakamura, Hiroshi Ozaki, Makoto Ueno, et al.
Nature Medicine (2024)
Open Access | Times Cited: 12
Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine
Ibraheem Dakilah, Amani A. Harb, Eman Abu‐Gharbieh, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Ibraheem Dakilah, Amani A. Harb, Eman Abu‐Gharbieh, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Revolutionizing cancer drug development: Harnessing the potential of basket trials
Vivek Subbiah, Howard A. Burris, Razelle Kurzrock
Cancer (2023) Vol. 130, Iss. 2, pp. 186-200
Closed Access | Times Cited: 17
Vivek Subbiah, Howard A. Burris, Razelle Kurzrock
Cancer (2023) Vol. 130, Iss. 2, pp. 186-200
Closed Access | Times Cited: 17
The future of precision cancer therapy might be to try everything
Elie Dolgin
Nature (2024) Vol. 626, Iss. 7999, pp. 470-473
Open Access | Times Cited: 6
Elie Dolgin
Nature (2024) Vol. 626, Iss. 7999, pp. 470-473
Open Access | Times Cited: 6
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
Cambridge Prisms Precision Medicine (2024) Vol. 2
Open Access | Times Cited: 6
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
Cambridge Prisms Precision Medicine (2024) Vol. 2
Open Access | Times Cited: 6
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design
Elena Fountzilas, Apostolia M. Tsimberidou, Henry Hiep Vo, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102703-102703
Closed Access | Times Cited: 5
Elena Fountzilas, Apostolia M. Tsimberidou, Henry Hiep Vo, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102703-102703
Closed Access | Times Cited: 5
Poly-pharmacology of existing drugs: How to crack the code?
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Identification of potentially actionable genetic variants in epithelial ovarian cancer: a retrospective cohort study
Charlotte Fieuws, Joni Van der Meulen, Kristiaan Proesmans, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Charlotte Fieuws, Joni Van der Meulen, Kristiaan Proesmans, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes
Mark Jesus M. Magbanua, Wen Li, Laura van ‘t Veer
Cancers (2024) Vol. 16, Iss. 10, pp. 1879-1879
Open Access | Times Cited: 5
Mark Jesus M. Magbanua, Wen Li, Laura van ‘t Veer
Cancers (2024) Vol. 16, Iss. 10, pp. 1879-1879
Open Access | Times Cited: 5
VenEx precisely predicts ven-aza response
Pamela S. Becker
Blood (2025) Vol. 145, Iss. 4, pp. 353-354
Closed Access
Pamela S. Becker
Blood (2025) Vol. 145, Iss. 4, pp. 353-354
Closed Access
The impact of integrated genomic analysis on molecular classifications and prognostic risk stratification in endometrial cancer: a Chinese experience
Qian Zheng, Ди Шао, Shu Jin, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Qian Zheng, Ди Шао, Shu Jin, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine
Breanna Mann, Nichole Artz, Rami Darawsheh, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Breanna Mann, Nichole Artz, Rami Darawsheh, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database
Maria Teresa Rizzo, Gaetano Pezzicoli, Camillo Porta, et al.
ESMO Open (2025) Vol. 10, Iss. 3, pp. 104294-104294
Open Access
Maria Teresa Rizzo, Gaetano Pezzicoli, Camillo Porta, et al.
ESMO Open (2025) Vol. 10, Iss. 3, pp. 104294-104294
Open Access
Clinical Validation of Local Versus Commercial Genomic Testing in Cancer: A Comparison of Tissue and Plasma Concordance
Lucy G. Faulkner, Lynne M. Howells, Susann Lehmann, et al.
Cancer Investigation (2025), pp. 1-22
Open Access
Lucy G. Faulkner, Lynne M. Howells, Susann Lehmann, et al.
Cancer Investigation (2025), pp. 1-22
Open Access
Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives
Sulin Wu, Rajat Thawani
Cancers (2025) Vol. 17, Iss. 5, pp. 801-801
Open Access
Sulin Wu, Rajat Thawani
Cancers (2025) Vol. 17, Iss. 5, pp. 801-801
Open Access
Prospective Evaluation of Structure-Based Simulations Reveal Their Ability to Predict the Impact of Kinase Mutations on Inhibitor Binding
Sukrit Singh, Vytautas Gapsys, Matteo Aldeghi, et al.
The Journal of Physical Chemistry B (2025)
Open Access
Sukrit Singh, Vytautas Gapsys, Matteo Aldeghi, et al.
The Journal of Physical Chemistry B (2025)
Open Access
Meningioma: Novel Diagnostic and Therapeutic Approaches
Carlen Yuen, M.Y. Zheng, Max A. Saint-Germain, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 659-659
Open Access
Carlen Yuen, M.Y. Zheng, Max A. Saint-Germain, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 659-659
Open Access
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
Pieter‐Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Pieter‐Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
The emerging role of Sotorasib plus Panitumumab combination therapy in colorectal cancer treatment
Emmanuel Kokori, Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, et al.
International Journal of Clinical Oncology (2025)
Closed Access
Emmanuel Kokori, Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, et al.
International Journal of Clinical Oncology (2025)
Closed Access
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer
Farasat Kazmi, Nipun Shrestha, Tiaotiao Liu, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Open Access
Farasat Kazmi, Nipun Shrestha, Tiaotiao Liu, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Open Access
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients
Julio Herrero Colomina, E. Johnston, Kate Duffus, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Julio Herrero Colomina, E. Johnston, Kate Duffus, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe
Georgina D. Barnabas, Tariq Ahmad Bhat, Verena Goebeler, et al.
EMBO Molecular Medicine (2025)
Open Access
Georgina D. Barnabas, Tariq Ahmad Bhat, Verena Goebeler, et al.
EMBO Molecular Medicine (2025)
Open Access
